{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:01:41Z","timestamp":1794499301301,"version":"4.9.1"},"publisher-location":"Cham","reference-count":24,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319199733","type":"print"},{"value":"9783319199740","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/5584_2015_144","type":"book-chapter","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T03:20:31Z","timestamp":1432783231000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Expression of HIF-1A\/VEGF\/ING-4 Axis in Pulmonary Sarcoidosis"],"prefix":"10.1007","author":[{"given":"W. J.","family":"Piotrowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kisza\u0142kiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pastuszak-Lewandoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"G\u00f3rski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Antczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Migdalska-S\u0119k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"G\u00f3rski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Doma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nawrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brzezia\u0144ska-Lasota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"144_CR1","doi-asserted-by":"crossref","unstructured":"American Thoracic Society: European Respiratory Society: World Association of Sarcoidosis and Other Granulomatous Disorders (1999) Statement on sarcoidosis. Am J Respir Crit Care Med 160:736\u2013755","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"144_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1378\/chest.130.4.982","volume":"130","author":"KM Antoniou","year":"2006","unstructured":"Antoniou KM, Tzouvelekis A, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Rachiotis G, Tzanakis N, Bouros D, Milic-Emili J, Siafakas NM (2006) Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 130:982\u2013988","journal-title":"Chest"},{"key":"144_CR3","doi-asserted-by":"crossref","unstructured":"Antoniou KM, Soufla G, Proklou A, Margaritopoulos G, Choulaki C, Lymbouridou R, Samara KD, Spandidos DA, Siafakas NM (2009) Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol 537929. doi:10.1155\/2009\/537929","DOI":"10.1155\/2009\/537929"},{"key":"144_CR4","first-page":"56","volume":"28","author":"RP Baughman","year":"2011","unstructured":"Baughman RP, Nagai S, Balter M, Costabel U, Drent M, du Bois R, Grutters JC, Judson MA, Lambiri I, Lower EE, Muller-Quernheim J, Prasse A, Rizzato G, Rottoli P, Spagnolo P, Teirstein A (2011) Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis 28:56\u201364","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"144_CR05","doi-asserted-by":"crossref","unstructured":"Chcia\u0142owski A, Chorostowska-Wynimko J, Fal A, Paw\u0142owicz R, Domaga\u0142a-Kulawik J (2011) Recommendation of the Polish Respiratory Society for bronchoalveolar lavage (BAL) sampling, processing and analysis methods. Pneumonol Alergol Pol 79(2):75\u201389 (Article in Polish)","DOI":"10.5603\/ARM.27675"},{"key":"144_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000245332","volume":"80","author":"A Cui","year":"2010","unstructured":"Cui A, Anhenn O, Theegarten D, Ohshimo S, Bonella F, Sixt SU, Peters J, Sarria R, Guzman J, Costabel U (2010) Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Respiration 80:372\u2013378","journal-title":"Respiration"},{"key":"144_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.biocel.2004.08.012","volume":"37","author":"MA D\u00e9ry","year":"2005","unstructured":"D\u00e9ry MA, Michaud MD, Richard DE (2005) Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37:535\u2013540","journal-title":"Int J Biochem Cell Biol"},{"key":"144_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2013.11.016","volume":"345","author":"C Gu\u00e9rillon","year":"2014","unstructured":"Gu\u00e9rillon C, Bigot N, Pedeux R (2014) The ING tumor suppressor genes: status in human tumors. Cancer Lett 345:1\u201316","journal-title":"Cancer Lett"},{"key":"144_CR8","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP (1999) ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149\u2013173","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"144_CR9","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153\u20132165","journal-title":"N Engl J Med"},{"key":"144_CR10","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1073\/pnas.0605669103","volume":"103","author":"KK Kim","year":"2006","unstructured":"Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103:13180\u201313185","journal-title":"Proc Natl Acad Sci U S A"},{"key":"144_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.disamonth.2009.04.008","volume":"55","author":"A Lazarus","year":"2009","unstructured":"Lazarus A (2009) Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon 55:649\u2013660","journal-title":"Dis Mon"},{"key":"144_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2014_106","author":"WJ Piotrowski","year":"2014","unstructured":"Piotrowski WJ, Kisza\u0142kiewicz J, Pastuszak-Lewandoska D, Antczak A, G\u00f3rski P, Migdalska-S\u0119k M, G\u00f3rski W, Czarnecka KH, Nawrot E, Doma\u0144ska D, Brzezia\u0144ska-Lasota E (2014a) TGF-\u03b2 and SMADs mRNA expression levels in pulmonary sarcoidosis. Adv Exp Med Biol. doi:10.1007\/5584_2014_106","journal-title":"Adv Exp Med Biol"},{"key":"144_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.20452\/pamw.2349","volume":"124","author":"WJ Piotrowski","year":"2014","unstructured":"Piotrowski WJ, M\u0142ynarski W, Fendler W, Wyka K, Marczak J, G\u00f3rski P, Antczak A (2014b) Associations between chemokine receptor cxcr3 ligands in bronchoalveolar lavage fluid and radiological pattern, clinical course and prognosis in sarcoidosis. Pol Arch Med Wewn 124:395\u2013402","journal-title":"Pol Arch Med Wewn"},{"key":"144_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00408-003-1028-8","volume":"181","author":"M Sekiya","year":"2003","unstructured":"Sekiya M, Ohwada A, Miura K, Takahashi S, Fukuchi Y (2003) Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis. Lung 181:259\u2013265","journal-title":"Lung"},{"key":"144_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1164\/rccm.201009-1393PP","volume":"183","author":"LA Shimoda","year":"2011","unstructured":"Shimoda LA, Semenza GL (2011) HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med 183:152\u2013156","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","volume":"99","author":"KR Stenmark","year":"2006","unstructured":"Stenmark KR, Fagan KA, Frid MG (2006) Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99:675\u2013691","journal-title":"Circ Res"},{"key":"144_CR17","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1001\/jama.289.24.3300","volume":"289","author":"KW Thomas","year":"2003","unstructured":"Thomas KW, Hunninghake GW (2003) Sarcoidosis. JAMA 289:3300\u20133303","journal-title":"JAMA"},{"key":"144_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s004280050135","volume":"432","author":"E Tolnay","year":"1998","unstructured":"Tolnay E, Kuhnen C, Voss B, Wiethege T, Muller KM (1998) Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Virchows Arch 432:61\u201365","journal-title":"Virchows Arch"},{"key":"144_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/1756-0500-5-654","volume":"5","author":"A Tzouvelekis","year":"2012","unstructured":"Tzouvelekis A, Ntolios P, Karameris A, Koutsopoulos A, Boglou P, Koulelidis A, Archontogeorgis K, Zacharis G, Drakopanagiotakis F, Steiropoulos P, Anevlavis S, Polychronopoulos V, Mikroulis D, Bouros D (2012) Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Res Notes 5:654","journal-title":"BMC Res Notes"},{"key":"144_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1513\/AnnalsATS.201209-078OC","volume":"10","author":"M Yamashita","year":"2013","unstructured":"Yamashita M, Mouri T, Niisato M, Kowada K, Kobayashi H, Chiba R, Satoh T, Sugai T, Sawai T, Takahashi T, Yamauchi K (2013) Heterogeneous characteristics of lymphatic microvasculatures associated with pulmonary sarcoid granulomas. Ann Am Thorac Soc 10:90\u201397","journal-title":"Ann Am Thorac Soc"},{"key":"144_CR21","doi-asserted-by":"crossref","first-page":"L818","DOI":"10.1152\/ajpcell.1998.275.3.C818","volume":"275","author":"AY Yu","year":"1998","unstructured":"Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL (1998) Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 275:L818\u2013L826","journal-title":"Am J Physiol"},{"issue":"Suppl 2","key":"144_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/2047-783X-15-S2-229","volume":"15","author":"TM Zielonka","year":"2010","unstructured":"Zielonka TM, Demkow U, Radzikowska E, Bialas B, Filewska M, \u017byci\u0144ska K, Obrowski MH, Kowalski J, Wardyn KA, Skopi\u0144ska-R\u00f3\u017cewska E (2010) Angiogenic activity of sera from interstitial lung disease patients in relations to pulmonary function. Eur J Med Res 15(Suppl 2):229\u2013234","journal-title":"Eur J Med Res"},{"key":"144_CR23","first-page":"120","volume":"68","author":"D Ziora","year":"2000","unstructured":"Ziora D, Dworniczak S, Niepsuj G, Niepsuj K, Jarosz W, Sielska-Sytek E, Ciekalska K, Oklek K (2000) Proangiogenic cytokines (bFGF and VEGF) in BALF from two different lung segments examined by high resolution computed tomography (HRCT) in patients with sarcoidosis. Pneumonol Alergol Pol 68:120\u2013130","journal-title":"Pneumonol Alergol Pol"}],"container-title":["Advances in Experimental Medicine and Biology","Noncommunicable Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2015_144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T23:50:36Z","timestamp":1748389836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/5584_2015_144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319199733","9783319199740"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/5584_2015_144","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-19974-0","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"29 May 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}